Agency Logo

DATA AND SURVEILLANCE

The above surveillance data is current as of February 29, 2020.

From the Respiratory Disease Epidemiologist - March 6, 2020:

West Virginia has declared influenza activity over MMWR Week 9 (February 23rd - February 29th) to be WIDESPREAD for the FluView national influenza surveillance report. Our surveillance indicators have either increased slightly or decreased slightly from MMWR Week 8. We continue to see co-circulation of Influenza Types A and B (likely Type A 2009 H1N1 and Type B Victoria) but are starting to see a predominance of Influenza Type A. It remains uncertain how long elevated influenza activity will last.

The CDC has recently published preliminary estimates of the 2019-2020 influenza vaccine effectiveness. It is recommended that all people six months and older who have not received an influenza vaccine this season be vaccinated against influenza. Locations that have influenza vaccinations available can be found at vaccinefinder.org. The CDC also recommends antiviral medications for the treatment of influenza.

Healthcare providers are encouraged to collect respiratory specimens and submit them to the Office of Laboratory Services (OLS) for confirmatory influenza and respiratory panel testing. For more information on how to submit respiratory specimens, please visit OLS's influenza webpage: https://dhhr.wv.gov/ols/labs/Pages/Influenza.aspx

Printable Surveillance Graphs